Related Experiment Video
Updated: Jun 10, 2026
Grossing of Non-neoplastic Globes, Including Fetal Eyes
Published on: May 30, 2025
[Focus on application of pathological examination in treatment of ocular tumours]
Abstract:
Ophthalmic pathology is not only a golden standard in diagnosing ocular tumors, but also provides the effective and fast criteria for evaluating the completeness of excision. The development of pathological biopsy in minimally invasive operation and targeted therapy facilitates the application of molecular pathology, and then, stimulates the development of pharmaco-pathology and targeted diagnostic pathology. After the application of these novel procedures into the treatment of ocular tumours, the pathologists are required to take part in the tumor treatment, and it also demands higher level ophthalmic pathologists and ocular tumor experts.
Insights
Ophthalmic pathology is crucial for diagnosing eye tumors and assessing surgical success. Advances in molecular pathology are driving new diagnostic and therapeutic approaches for ocular tumors.
Area of Science:
- Ophthalmology
- Oncology
- Pathology
Background:
- Ophthalmic pathology is the gold standard for diagnosing ocular tumors and evaluating surgical excision completeness.
- Minimally invasive surgery and targeted therapies have spurred the integration of molecular pathology in ocular oncology.
Discussion:
- The evolution of pathological biopsy techniques supports minimally invasive operations and targeted therapies.
- Molecular pathology's application stimulates advancements in pharmaco-pathology and targeted diagnostic pathology for eye tumors.
Key Insights:
- Ophthalmic pathology provides essential diagnostic and prognostic information for ocular tumors.
- Novel procedures in ocular tumor treatment necessitate pathologist involvement in patient care.
- The field demands higher expertise in ophthalmic pathology and ocular tumor management.
Outlook:
- Continued integration of molecular diagnostics will refine ocular tumor treatment strategies.
- Enhanced collaboration between pathologists and clinicians is vital for advancing ocular oncology.
- Future developments will focus on personalized medicine approaches in ophthalmic pathology.
